FDA approves first needle-free flu vaccine injection system

BioCSL and PharmaJet have a new solution for uptake-hampering needlephobia. On Tuesday, the FDA approved the latter's Stratis Needle-Free Jet Injector for the delivery of bioCSL's seasonal flu vaccine, Afluria. The PharmaJet injector delivers the vaccine by means of a narrow, precise fluid stream that penetrates the skin in about one-tenth of a second, the companies said. Release

Suggested Articles

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.

GSK's Shingrix has nabbed a huge chunk of the U.S. shingles-shot market, just five months after it was approved by the FDA.